#9: ILC2s and cancer

An episode of the Inflammatory Content podcast, hosted by Kellen Cavagnero, Ph.D., titled "#9: ILC2s and cancer" was published on July 18, 2020 and runs 13 minutes.

July 18, 2020 ·13m · Inflammatory Content

0:00 / 0:00

Summary

Cutting-edge approaches to combat tumor development involve transplantation of anti-tumor T cells and natural killer cells. Natural killer (NK) cells belong to a greater family of innate lymphoid cells which includes the more recently described group 1, 2, and 3 innate lymphoid cells (ILCs). Unlike NK and T cells, the role of non-NK ILCs in tumor immunity remains unclear. In this episode, Kellen highlights a 2020 report in Nature describing the role of ILC2s in pancreatic cancer. The article was written by John Alec Moral and colleagues and is titled “ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity”.Paper: https://www.nature.com/articles/s41586-020-2015-4Review: https://pubmed.ncbi.nlm.nih.gov/30209347/To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero). Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.

Episode Description

Cutting-edge approaches to combat tumor development involve transplantation of anti-tumor T cells and natural killer cells. Natural killer (NK) cells belong to a greater family of innate lymphoid cells which includes the more recently described group 1, 2, and 3 innate lymphoid cells (ILCs). Unlike NK and T cells, the role of non-NK ILCs in tumor immunity remains unclear. In this episode, Kellen highlights a 2020 report in Nature describing the role of ILC2s in pancreatic cancer. The article was written by John Alec Moral and colleagues and is titled “ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity”.

Paper: https://www.nature.com/articles/s41586-020-2015-4

Review: https://pubmed.ncbi.nlm.nih.gov/30209347/

To help us spread science, please consider writing a review, sharing this episode with your friends and colleagues, or donating to support our work (Venmo @Kellen-Cavagnero).

Please reach out to us via email ([email protected]) or Twitter (@KellenCavagnero) with any questions, comments, topic suggestions, etc.

Share this episode

Similar Episodes

Discussing Signatura

Apr 2, 2026 ·29m

Sarah Norton - Living with Stage IV IBC

Feb 5, 2026 ·37m

We Have a Code....What's Next?

Sep 4, 2025 ·35m

Journey of tackling Stage 3b Inflammatory Breast Cancer with a Newborn

Jul 30, 2025 ·53m

Ink, Identity, and IBC: Katy’s Journey Through HER2-Positive Inflammatory Breast Cancer

Jul 8, 2025 ·40m

Dr. Azadeh Nasrazadani, MD Anderson Department of Breast Medical Oncology,

Jun 26, 2025 ·35m

Similar Podcasts

3-Day Anti-Inflammatory Revitalize Challenge Anti-Inflammatory Living Discover the simple 3-step formula to reclaim your energy, reduce flare-ups & finally lose that stubborn weight Crohn’s & Colitis Foundation Perspectives ReachMD As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support f About IBD Amber J Tresca Crohn's disease and ulcerative colitis (collectively known as inflammatory bowel disease) are about more than diarrhea: they affect the whole person. About IBD focuses on health and lifestyle issues important to people living with Crohn's or colitis. IBD patients, doctors, therapists, and care partners give their tips and advice on topics including diet, nutrition, treatments, mental health, family dynamics, and sexuality as it relates to living with IBD. IBD Round Table Discussion ( Video ) – The Crohn's Colitis Effect The Crohns Colitis Effect The Crohn's Colitis Effect is a non-profit Inflammatory Bowel Disease advocacy group specializing in spreading awareness for IBD, Crohn's, and Colitis. Our monthly IBD Round Table Discussion brings some of the leading IBD Advocates together to talk about this invisible illness and what we can do to make life better. Regardless if you are a patient, caregiver, or just someone looking to educate themselves more about this gastrointestinal disease, there is something for everyone in these webcasts. Our mission is to make IBD a "household" name!

URL copied to clipboard!